Article
The association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept.
Journal of clinical laboratory analysis - 1 Nov 2017
Zhao Shengchun, Chen Hongwei, Wu Guolin, Zhao Chen
Abstract excerpt
BACKGROUND: To discover how NLRP3 and TNFRSF1A polymorphisms affect the efficacy of traditional medicine and etanercept for ankylosing spondylitis (AS) patients. METHODS: Single nucleotide polymorphism (SNP) and haplotype analyses were conducted based on determined NLRP3 and TNFRSF1A among AS patients. We subsequently analyzed the relationship between relevant clinical indexes and polymorphisms of NLRP3 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
